1-6 of 6
Daniel Martínez-Carballeira, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Post-Remission Treatment with Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) in Adult Patients with High-Risk (HR) Philadelphia Chromosome-Negative (Ph-neg) Acute Lymphoblastic Leukemia (ALL) According to Their Minimal Residual Disease (MRD). Final Results of the Pethema ALL-HR-11 Trial

Josep-Maria Ribera, MD PhD, Mireia Morgades, M.Prob.S, Juana Ciudad, PhD, Pau Montesinos, MD PhD, Pere Barba, MD PhD, Irene García-Cadenas, María José Moreno, MD, Susana Vives, MD, Jordi Esteve, Cristina Gil, Silvia Monsalvo, MD, María Teresa Artola, MD, Jordi Ribera, PhD, Eulàlia Genescà, PhD, Mar Tormo, MD PhD, Marta Cervera, MD, Daniel Martínez-Carballeira, MD, Andrés Novo, MD, José González-Campos, MD, Beatriz Soria, MD, Arancha Bermúdez, MD, Aurelio López Martínez, MD, Santiago Mercadal, MD, Rosa Fernández-Martín, MD, Rosa Coll, MD, Josefina Serrano, Maria Luz Amigo, MD, Pilar Martínez-Sánchez, Juan-Miguel Bergua, MD, Alfons Serrano-Maestro, MD, Alberto Giménez Conca, MD, Susana Barrena, PhD, Isabel Granada, PhD, Evarist Feliu, MD PhD, Alberto Orfao, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 826.
https://doi.org/10.1182/blood-2019-123613
Published: 2019
Journal Articles

Long Term Discontinuation of Eltrombopag after Remission in Primary Immune Thrombocytopenia: 8-Year Follow-up Data from 15 Spanish Centers

Tomas Jose Gonzalez-Lopez, Fernando Fernandez-Fuertes, Maria Cristina Pascual Izquierdo, PhD MD, Isabel Caparros, Silvia Bernat, Carmen Pastoriza, Maria Paz Martínez-Badas, Pável E Olivera, MD, Gonzalo Caballero, MD, Jose Angel Hernandez-Rivas, MD PhD, Daniel Martínez-Carballeira, MD, Inmaculada Soto Ortega, Gloria Perez Segura, Isabel Regalado, Blanca Sánchez-González, Isidro Jarque, Luis Javier garcia Frade, MD, Miguel A. Sanz
Journal: Blood
Blood (2019) 134 (Supplement_1): 2352.
https://doi.org/10.1182/blood-2019-129274
Published: 2019
Journal Articles

Rituximab and Specific Therapy for Patients with Burkitt's Leukemia and Lymphoma. Results of the BURKIMAB14 Trial from the Spanish Pethema and Geltamo Groups in 80 Patients

Josep-Maria Ribera, MD PhD, Olga García, Marta Cervera, MD, Carlos Rguez, Maialen Sirvent, Ferran Vall-Llovera, MD, Pau Abrisqueta, MD PhD, Josefina Serrano, Buenaventura Buendía, Pau Montesinos Fernandez, MD PhD, Susana Vives, MD, Juan Miguel Bergua Burgues, Mariana Beatriz Bastos-Oreiro, PhD MD, Evelyn Acuña, María José Moreno, MD, Irene García-Cadenas, Maria Jose Terol, Jesús María Hernández-Rivas, MD PhD, Antonio Garcia-Guiñon, MD, Pilar Herrera Puente, Santiago Mercadal, MD, Iulia Ivan, Antonia Cladera, Eva Gimeno Vázquez, Anna Torrent, Alfons Serrano-Maestro, MD, Cristina Barrenetxea, Daniel García, MD, Reyes Arranz, Ana Sebrango, Natalia Alonso, Daniel Martínez-Carballeira, MD, Juan-Manuel Sancho, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2584.
https://doi.org/10.1182/blood-2019-125683
Published: 2019
Journal Articles

Characteristics and Outcome of Early T Cell Precursor ALL (ETP-ALL) Patients Treated with High-Risk Spanish Pethema Protocols

Eulalia Genesca, PhD, Mireia Morgades, M.Prob.S, Pau Montesinos, MD PhD, Pere Barba, MD, Cristina Gil, MD PhD, Ramon Guàrdia, MD, Maria Jose Moreno, MD, Daniel Martínez-Carballeira, MD, Irene García-Cadenas, Susana Vives, MD, Jordi Ribera, José González-Campos, MD, Marina Diaz-Beyá, MD, Santiago Mercadal, MD, Maria Teresa Artola, MD, Antonia Cladera, MD, Mar Tormo, MD PhD, Arancha Bermudez, MD, Ferran Vall-Llovera, MD, Pilar Martinez, MD, María-Luz Amigo, MD, Juan-Miguel Bergua, MD, María Calbacho, MD, Jesús-María Hernández-Rivas, MD PhD, Silvia Monsalvo, Andrés Novo, MD, Marta Cervera, MD, Antonio Garcia-Guiñon, MD, Jordi Junca, MD, Juana Ciudad, PhD, Alberto Orfao, MD PhD, Josep-Maria Ribera, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1553.
https://doi.org/10.1182/blood-2018-99-114559
Published: 2018
Journal Articles

Results of the Full Pediatric, Minimal Residual Disease (MRD)-Oriented Trial LAL-RI/2008 for Adolescents and Young Adults (AYA) with Standard Risk (SR), Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL)

Josep-Maria Ribera, MD, Mireia Morgades, M.Prob.S, Pau Montesinos, MD PhD, Daniel Martínez-Carballeira, MD, Cristina Gil, MD, Pere Barba, MD, Mar Tormo, MD PhD, Raimundo García-Boyero, MD, Ramon Guàrdia, MD, María Pedreño, MD, Santiago Mercadal, MD, Andrés Novo, MD, Jesús-María Hernández-Rivas, MD PhD, Juan Bergua, MD, José González-Campos, MD, María-Luz Amigo, MD, Marta Cervera, MD, Pilar Martínez-Sánchez, MD, Rodrigo Martino, MD PhD, María Calbacho, MD, Antoni Garcia-Guiñon, MD, Susana Vives, MD, Evarist Feliu, MD PhD, Alberto Orfao, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1273.
https://doi.org/10.1182/blood.V130.Suppl_1.1273.1273
Published: 2017
Journal Articles

Is the Outcome of Patients with High Risk T-Cell Acute Lymphoblastic Leukemia Improving in the Era of Pediatric—Inspired Protocols? a Comparison of 2 Consecutive Pethema Trials

Pere Barba, MD, Mireia Morgades, M.Prob.S, Pau Montesinos, MD PhD, Cristina Gil, MD, Maria Laura Fox, Juana Ciudad, maria Jose Moreno, José González-Campos, MD, Eulalia Genesca, Daniel Martínez-Carballeira, MD, Rodrigo Martino, MD PhD, Susana Vives, MD, Ramon Guàrdia, MD, Santiago Mercadal, MD, Maria Teresa Artola, Antonia Cladera, Mar Tormo, MD PhD, Jordi Esteve, MD, Juan Bergua, MD, Ferran Vall-Llovera, Jordi Ribera, Pilar Martínez-Sánchez, MD, María-Luz Amigo, MD, Arancha Bermudez, María Calbacho, MD, Jesús-María Hernández-Rivas, MD PhD, Evarist Feliu, MD PhD, Josep-Maria Ribera, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1323.
https://doi.org/10.1182/blood.V130.Suppl_1.1323.1323
Published: 2017